Android Mobile Devices to Assist Routine Anticipation for Autistic Children

October 28, 2015 updated by: Annie France Frère Slaets, University of Mogi das Cruzes
The objective of this work is to develop an application to run on a mobile device Android tablet that features visual routines for autistic children.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Autism is a disorder characterized by social deficits, and among others by changes in communication. The diagnosis of this disorder remains accomplished by direct assessment the individual's behavior, according to specific clinical criteria present the classification systems of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Therapists teach autistic to communicate with the help of symbols and auxiliary anticipation and communication routines, usually using the Picture Exchange Communication System (PECS), or photos. However these are presented in transition PECS cards and do not follow the children in activities that develop outside the school environment. The objective of this work is to develop an application to run on a mobile device Android tablet that features the visual routines.

In this way the routines can be accessed outside the school environment. This technology is easy to use and facilitates data entry by touching the screen, was developed using the Unified Modeling Language (UML), Javascript, Apache Web server and Web browser Chrome. The application validation, will be held with 10 autistic and 2 teachers from the center of inclusion and support for autistic. Teachers should insert the activities programmed for each autistic student. Tablet in student performance in communicating with this tablet will be measured. Parents or guardians knowledge with the PECS system will be trained and will be evaluated on their autonomy inserting images, audio and subtitles. The application should aid communication, cause the autistic understand the sequence of events in daily life, decreasing their aggression because of not knowing what will be their next activity. Participation in this research poses no risk or harm the concerned person. If during the research participant decides not anymore have the freedom to do so without incurring any damage you. The technical validation proposal is necessary for it to be used by people with autism. If validated in a positive way, the technique could improve the quality of life of these people and their families.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
    • Sao Paulo
      • Guarulhos, Sao Paulo, Brazil
        • Centro de inclusão e Apoio ao Autista de Guarulhos (CIAAG)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 9 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a diagnosis of autism development by DSM-IV
  • Have sufficient motor skills to perform operations on a tablet
  • Be aware of PECS
  • Children should be accustomed to the visual routines used in

Exclusion Criteria:

  • Have visual impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Autism
Using the app to assist routine anticipation for autistic children in Android mobile devices
Other: Using the app to assist routine anticipation
Using the app to assist routine anticipation for autistic children in Android mobile devices

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increase in verbal communication
Time Frame: 1 month
Increased verbal communication in autistic individuals (as a percentage)
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Mogi das Cruzes

Investigators

  • Principal Investigator: Annie F Frere Slaets, PhD, University of Mogi Cruzes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

October 1, 2015

Study Completion (Anticipated)

December 1, 2015

Study Registration Dates

First Submitted

October 28, 2015

First Submitted That Met QC Criteria

October 28, 2015

First Posted (Estimate)

October 29, 2015

Study Record Updates

Last Update Posted (Estimate)

October 29, 2015

Last Update Submitted That Met QC Criteria

October 28, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 49354415.0.0000.5497

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism

Clinical Trials on Using the app to assist routine anticipation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe